Gsk Share Discussion Threads

[igoe104] 24/5/2024 08:19

Traders have been spooked by the general election announcement and are cashing in, seems to be the situation with most large caps at the moment..

These traders are a very nervy bunch, all it takes for the king to break a nail and they go all cash again, must be constantly in and out the market...

[drk1] 24/5/2024 08:15

Thought that news would give the share price a nice little boost - let's see how they react over the pond later on. ;-)

[panache1] 24/5/2024 07:07

Issued: 23 May 2024, London UK Statement: Zantac (ranitidine) litigation - Valadez and Williams cases · Jury in Valadez case in Illinois state court finds GSK not liable for plaintiff's colorectal cancer· Verdict is consistent with scientific consensus that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer· GSK will continue to vigorously defend itself against all other claims· Next Zantac trial (Williams) due to start in Illinois dismissed GSK plc (LSE/NYSE: GSK) welcomes today's jury verdict in the Valadez case in Illinois state court finding in GSK's favour in the first Zantac case to go to trial. This outcome is consistent with the scientific consensus that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer, supported by 16 epidemiological studies looking at human data regarding the use of ranitidine. GSK will continue to vigorously defend itself against all other claims. Prior to this verdict, the court rejected the Plaintiff's ability to request punitive damages. Separately, the company welcomed the recent court ruling dismissing the next Zantac trial (Williams) that was due to start on 23 May 2024. In the Williams case, the Illinois state court dismissed the case before trial on the basis that GSK was not the brand manufacturer of over-the-counter Zantac at the time the Plaintiff allegedly used it and should not be liable for any subsequent over-the-counter Zantac use. ?

[dplewis1] 24/5/2024 07:07

Verdict is consistent with scientific consensus that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer

[lippy4] 22/5/2024 16:45

its typical american plundering by lawsuit with out any real evidence as every body jumps on the money wagon..

[zho] 22/5/2024 16:06

GSK PLC (LSE:GSK, NYSE:GSK) may face a settlement of up to $2 billion to resolve thousands of lawsuits related to Zantac, a heartburn medication linked to cancer, according to an estimate from the investment banking arm of Barclays.

Zantac was pulled from the market in 2019 after the US Food and Drug Administration (FDA) found it contained N-nitrosodimethylamine (NDMA), a probable carcinogen. This discovery led to numerous lawsuits from patients who alleged that they developed cancer after using the drug.

The potential figure for GSK is informed by recent settlements by other pharmaceutical companies, notably Pfizer.

According to the Financial Times, Pfizer recently settled more than 10,000 US Zantac cases for up to $250 million, which sets a benchmark of approximately $25,000 per case. This figure has influenced Barclays' estimate of GSK's potential settlement costs.

[abdullla] 22/5/2024 16:03

More majic

[tradermichael] 22/5/2024 09:07

16 pounds is 150p away from 1750p. So is 19 pounds ..... ;0)

[abdullla] 22/5/2024 08:09

Not far from the good old 16 pounds

[tradermichael] 21/5/2024 15:46

In a statement, GSK said it will defend against Valisure's meritless lawsuit, and that the FDA has found the lab's tests "scientifically flawed and unreliable."
GSK also said there remains no consistent or reliable evidence that ranitidine increases cancer risks.

[pcok] 21/5/2024 13:36

Don't have a Bloomberg subscription. Can you summarise or suggest a different link if possible. TIA.

[zho] 21/5/2024 10:25

GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay

The story of Emma Walmsley’s turnaround of the British drugmaker

[tradermichael] 21/5/2024 10:07

Well, a therapy for Asthma has taken that long - the drug is part of a range of 'new technology' advances (Monoclonal antibodies (MABs) are a type of targeted drug therapy.)

[alphorn] 21/5/2024 09:43

An experimental drug (which has taken 60 years of research), depemokimab............
So how strong is the patent?

[tradermichael] 21/5/2024 09:34

This morning GSK announced some big pipeline news. An experimental drug (which has taken 60 years of research), depemokimab, reduced asthma attacks in late-stage trials. The results pave the way for a treatment the company thinks could exceed £3 billion in sales.

[rikky72] 21/5/2024 09:11

Sad how many vultures and scam artists a company of GSK's size attracts.. hopefully this whole episode can be put to bed soon!

[tradermichael] 21/5/2024 08:38

Why would the Valisure 'whistleblower' emerge so late in the day, ahead of big court case??

Valisure themselves have been accused of applying 'junk science' to their own work many times before - as summarised by Judge Rosenberg.

Valisure’s role in the Zantac and other consumer lawsuits deserves more scrutiny. Its report that the diabetes drug metformin contained high levels of NDMA also triggered a blizzard of lawsuits. Valisure made headlines again in recent months after reporting scary-high levels of the carcinogen benzene in sunscreens and dry shampoos.

On December 5, 2022, the FDA sent Valisure an eight-page letter criticizing its data controls, equipment and failure to “establish and document the accuracy, sensitivity, specificity, and reproducibility of its test methods.” A spokesperson said Valisure will respond to the FDA letter but offered no comment on the judge’s ruling.

The Valisure methods and plaintiff attorney suits look like a litigation scam, and congratulations to Judge Rosenberg for exposing it.

[supermarky] 21/5/2024 08:17

Hopefully, my plan is working after selling half at 18.138 just before xd after such a strong run. We will see.

[abdullla] 21/5/2024 08:06

Sharp drop bad news

[tradermichael] 17/5/2024 08:27

Highly unlikely ..... ;0)

[mister md] 17/5/2024 08:03

Any chance of them returning proceeds as a special dividend ?

[tradermichael] 17/5/2024 07:59

GSK has raised almost £1.3billion from selling its entire remaining stake in consumer health firm Haleon, which span-out from the FTSE 100 drugmaker in July 2022.

The pharma giant initially retained a 12.9 per cent stake in Haleon after its IPO and, having now sold its shares, has raised a total of around £3.9billion.

GSK said in a short statement this morning: 'GSK's exit of its position in Haleon is consistent with its previous commitments to monetise its holding in a disciplined manner.'

[lippy4] 16/5/2024 21:11

sold out of gsk originally before they split from haleon and bought back into gsk only which i thought was wise in my view..